Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210027927 210013499 null null Palliative (P) 2013-04-28 2013-05-14 CNS Low Grade Glioma Vinblastine N N 210041073 VINBLASTINE
210027928 210013501 1.78 36 Palliative (P) 2014-02-26 2014-02-26 PONATINIB N N 210041084 CARBOPLATIN + ETOPOSIDE
210027929 210013503 1.78 84.6 Disease modification (D) 2015-06-10 2015-06-10 Methotrexate High Dose (3g/m2) N N 210041092 CHOP
210027930 210013505 1.6 103.6 Palliative (P) 2016-01-02 2016-02-07 Cladribine (subcut) 5 days Y N 210041101 CLADRIBINE
210027931 210022457 1.72 78.4 Curative (C) 2016-06-03 2016-07-31 CYCLOPHOSPHAMIDE N N 210041103 CYCLOPHOSPHAMIDE
210027932 210022457 1.75 94.4 Disease modification (D) 2017-01-07 2017-03-25 Inotuzumab Ozogamicin N N 210041103 INOTUZUMAB OZOGAMICIN
210027933 210013508 1.35 55 Curative (C) null 2017-06-14 Bevacizumab 10mg/kg Y N 210041106 RIALTO TRIAL
210027934 210013510 1.9 null Disease modification (D) 2016-04-15 2016-04-21 Inotuzumab Ozogamicin N N 210041115 PONATINIB
210027935 210013512 null 30 Curative (C) 2015-01-17 2015-01-27 Vinblastine 2 N 210041122 VINBLASTINE
210027936 210022462 1.86 null Palliative (P) 2018-04-29 2018-06-17 Cyclophosphamide + Vincristine N N 210041127 PONATINIB
210027937 210013516 1.6 85.4 Curative (C) null 2015-05-22 Methotrexate High Dose (3g/m2) null Y 210041160 METHOTREXATE HIGH DOSE
210027938 210013517 1.83 69 Curative (C) null 2013-06-19 CNS Low Grade Glioma Vinblastine null N 210041181 VINBLASTINE
210027939 210013518 1.86 66 null 2017-08-26 2017-08-26 Bevacizumab 10mg/kg 02 N 210041191 PONATINIB
210027940 210013520 null null Palliative (P) 2017-11-24 2017-11-26 CYCLOPHOSPHAMIDE 2 N 210041193 CYCLOPHOSPHAMIDE
210027941 210013525 0 83.5 Curative (C) null 2018-05-30 LOMUSTINE + PROCARBAZINE null null 210041199 LOMUSTINE + PROCARBAZINE
210027942 210013529 1.64 61.6 Disease modification (D) null 2017-12-03 CYCLOPHOSPHAMIDE N N 210041223 CYCLOPHOSPHAMIDE
210027943 210028089 null 67.1 Palliative (P) 2017-06-15 2017-08-29 UKALL XII Consolidation 2 & 4 N N 210041236 RIALTO TRIAL
210027944 210013530 1.68 32.9 Disease modification (D) 2013-08-28 2013-08-28 Methotrexate High Dose (3g/m2) N N 210041244 METHOTREXATE HIGH DOSE
210027946 210022470 1.67 11.4 Palliative (P) 2016-10-09 2016-11-05 PONATINIB N N 210041263 BENDAMUSTINE
210027947 210013536 1.64 60 Adjuvant (A) 2018-06-07 2018-06-09 UKALL XII Consolidation 2 & 4 02 N 210041266 CYCLOPHOSPHAMIDE + VINCRISTINE
210027948 210013538 1.77 null Curative (C) 2016-03-13 2016-03-13 CHLORAMBUCIL + OFATUMUMAB 2 N 210041279 CYCLOPHOSPHAMIDE + VINCRISTINE
210027949 210013540 null 26 Curative (C) 2017-11-25 2017-12-17 CLADRIBINE 02 N 210041303 CLADRIBINE
210027950 210013542 0 79.2 null 2018-02-16 2018-03-09 LOMUSTINE + PROCARBAZINE N N 210041335 LOMUSTINE + PROCARBAZINE
210027951 210013545 1.67 null null 2015-09-09 2015-09-17 Cladribine (subcut) 5 days N N 210041346 CLADRIBINE
210027952 210013547 1.62 61.6 Disease modification (D) null 2017-09-14 Cladribine (subcut) 5 days Y N 210041346 CLADRIBINE
210027953 210022475 1.7 74.6 Palliative (P) 2015-09-16 2016-02-03 LOMUSTINE + PROCARBAZINE null null 210041357 LOMUSTINE + PROCARBAZINE
210027954 210022477 null null Curative (C) 2014-12-11 2014-12-12 RIALTO TRIAL 02 N 210041385 CYCLOPHOSPHAMIDE + VINCRISTINE
210027955 210013557 1.77 71.6 Palliative (P) 2018-05-01 2018-08-28 R GCVP Y N 210041403 NELARABINE
210027956 210013560 1.53 94.8 Disease modification (D) null 2017-05-04 RIALTO TRIAL N N 210041408 CARBOPLATIN + ETOPOSIDE
210027957 210033673 1.68 80.8 null 2014-05-29 2014-06-04 CARBOPLATIN + VINCRISTINE null Y 210041423 CARBOPLATIN + VINCRISTINE
210027958 210022481 null 115 Curative (C) 2016-07-01 2016-07-05 LOMUSTINE + PROCARBAZINE 2 N 210041428 LOMUSTINE + PROCARBAZINE
210027959 210013565 0.85 15.4 null 2015-06-26 2016-01-09 LOMUSTINE + PROCARBAZINE N N 210041452 LOMUSTINE + PROCARBAZINE
210027960 210013566 0.87 65 null null 2015-05-11 Nelarabine null null 210041459 BENDAMUSTINE
210027961 210013570 1.67 69 Disease modification (D) 2015-09-29 2015-09-29 RIALTO TRIAL N N 210041472 ERWINIA ASPARAGINASE
210027962 210013571 1.88 101 Disease modification (D) null 2014-12-21 PONATINIB N N 210041488 PONATINIB
210027963 210022485 null null Palliative (P) 2013-09-03 2013-09-12 Bendamustine + prednisolone 2 N 210041488 METHOTREXATE HIGH DOSE
210027964 210013572 1.9 12.8 Disease modification (D) 2014-08-16 2015-03-02 Nelarabine N N 210041504 BEVACIZUMAB
210027965 210013573 1.88 89.9 Adjuvant (A) 2016-11-15 2017-02-15 Procarbazine N null 210041517 PROCARBAZINE
210027966 210013574 1.82 null Disease modification (D) 2010-12-31 2013-04-10 CARBOPLATIN + VINCRISTINE N N 210041519 CARBOPLATIN + VINCRISTINE
210027967 210013576 0 null null 2013-12-27 2014-04-05 Methotrexate High Dose (3g/m2) N N 210041526 CARBOPLATIN + ETOPOSIDE
210027968 210013578 1.83 68 Curative (C) 2018-09-17 2018-09-17 Cyclophosphamide TBI Allograft 02 N 210041546 CYCLOPHOSPHAMIDE
210027969 210022489 1.83 90 Curative (C) 2015-05-08 2015-05-18 CLADRIBINE 02 N 210041547 CLADRIBINE
210027970 210013583 1.64 77 Disease modification (D) 2018-04-03 2018-10-17 Pentostatin N N 210041556 INOTUZUMAB OZOGAMICIN
210027971 210022491 1.61 null Palliative (P) 2018-06-19 2018-06-26 Inotuzumab Ozogamicin N N 210041569 CARBOPLATIN + ETOPOSIDE
210027972 210013587 1.23 66.5 Disease modification (D) 2014-04-18 2014-04-18 IDELALISIB N N 210041577 BEVACIZUMAB
210027973 210013588 1.78 null Adjuvant (A) 2017-05-24 2017-05-24 Methotrexate High Dose (3g/m2) N N 210041579 PENTOSTATIN
210027974 210028103 0 30 Palliative (P) 2015-03-05 2015-03-05 Procarbazine N N 210041584 PROCARBAZINE
210027975 210038806 null null Palliative (P) null 2015-03-14 Methotrexate High Dose (3g/m2) null N 210041599 CVP R
210027976 210038806 1.6 33.5 Curative (C) 2018-01-23 2018-01-30 CHLORAMBUCIL + OFATUMUMAB 02 N 210041599 INOTUZUMAB OZOGAMICIN
210027977 210037863 null 79.2 Curative (C) 2013-10-10 2013-10-28 Cyclophosphamide Fludarabine (Oral) N N 210041615 CYCLOPHOSPHAMIDE + FLUDARABINE